- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.10. | Nexalin Technology, Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 08.10. | Nexalin Technology notifies Nasdaq compliance on minimum bid price | 2 | Seeking Alpha | ||
| 08.10. | Nexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing | 447 | GlobeNewswire (Europe) | HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain... ► Artikel lesen | |
| 01.10. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 01.10. | Why Is Nexalin Technology Stock Gaining Thursday? | 1 | Benzinga.com | ||
| 01.10. | Nexalin Technology, Inc.: Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation | 400 | GlobeNewswire (Europe) | Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync across seven countries and more than 300 million people, with a structured pricing framework... ► Artikel lesen | |
| 29.09. | Nexalin appoints Robert DiTota as senior strategic advisor | 9 | Investing.com | ||
| 29.09. | Nexalin Technology, Inc.: Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy | 2 | GlobeNewswire (USA) | ||
| 22.09. | Nexalin Technology, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 11.09. | RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV | 734 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 11, 2026 / RedChip Companies will air interviews with Anixa Biosciences Inc. (NASDAQ:ANIX) and Nexalin Technology Inc. (NASDAQ:NXL) on the RedChip Small Stocks... ► Artikel lesen | |
| 03.09. | Nexalin Technology, Inc.: Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer's Patients; ADAS-Cog ... | 3 | GlobeNewswire (USA) | ||
| 27.08. | Nexalin Technology beschließt Reverse-Aktiensplit im Verhältnis 1:30 | 3 | Investing.com Deutsch | ||
| 27.08. | Nexalin Technology approves 1-for-30 reverse stock split | 3 | Investing.com | ||
| 27.08. | Nexalin Technology announces 1-for-30 reverse stock split | 2 | Seeking Alpha | ||
| 27.08. | Nexalin Technology, Inc.: Nexalin Technology Announces Reverse Stock Split | 506 | GlobeNewswire (Europe) | HOUSTON, TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), announces that its board of directors has approved a 1-for-30 reverse stock split... ► Artikel lesen | |
| 27.08. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.08. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 27.07. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | Nexalin Technology, Inc.: Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company's Proprietary DIFS Platform | 1 | GlobeNewswire (USA) |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,602 | -0,04 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,072 | -2,96 % | PAUKENSCHLAG: Könnte die Aktie von Sernova Biotherapeutics nach 12,7 % Plus jetzt komplett durchstarten? - Das dürfen Sie nicht verpassen! | ||
| CERENOME | 1,394 | +1,75 % | Cerenome, Inc.: Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ' | ||
| ATOSSA THERAPEUTICS | 2,280 | +0,88 % | Atossa Therapeutics: Stammaktien handeln ab sofort gekoppelt mit Contingent Value Rights | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,400 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,625 | -2,65 % | Joint Venture von Co-Diagnostics zu saudi-arabischem Fertigungsforum eingeladen | ||
| QUIDELORTHO | 12,585 | +0,36 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,300 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,490 | 0,00 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,220 | -0,71 % | Clover Health Investments, Corp.: Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States | ||
| SENSEONICS | 7,250 | +2,11 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,377 | -2,00 % | Nanox meldet vorläufigen Q3-Umsatz von bis zu $4,4 Millionen | ||
| TEMPEST THERAPEUTICS | 0,527 | +0,57 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 1,030 | 0,00 % | IMUNON veräußert ThermoDox-Rechte an VoxelDox Therapeutics |
Das Unternehmen NEXALIN TECHNOLOGY INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,030 (-1,48 %) liegt der Kurs bei 2,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.